Author: Eunoia Consulting Co. | Published: September 1, 2026
FHIR provides a common exchange language, but governance makes healthcare data trustworthy enough for AI. Six practical controls help establish accountable, traceable, and fit-for-purpose data.
Healthcare organisations do not become AI-ready because they acquire a model. They become AI-ready when they can reliably explain where the model’s inputs came from, what those inputs mean, how complete they are, who is accountable for them, and what happens when the data changes.
That is a data-governance challenge before it is an AI challenge. Fast Healthcare Interoperability Resources (FHIR) can help because it provides a widely used, API-focused standard for representing and exchanging health information. But FHIR alone does not make a dataset fit for a clinical, operational, or revenue-cycle AI use case. It creates a common exchange language; governance determines whether the exchanged data is trustworthy enough to use. [1]
The practical goal is not to “convert everything to FHIR.” It is to establish six controls that make data usable, traceable, and safe for the particular AI decisions your organisation wants to support.
Start with the workflow decision, not the data warehouse. Ask what the AI-enabled process is expected to do, who will use its output, what the permitted action is, and what happens when the output is absent or uncertain.
For example, a system that prioritises prior-authorisation work needs different data controls from a system that drafts patient communications. The first may depend on payer rules, service codes, diagnosis context, submission history, and workflow status. The second may depend on approved knowledge sources, communication preferences, and human-review boundaries.
Write an AI data-use statement that includes the purpose, population, allowed inputs, excluded inputs, users, authorised actions, human oversight, and outcome measures. This becomes the standard against which data quality is evaluated. Without it, a team may be able to show that data is present without being able to show that it is fit for purpose.
Data stewardship cannot be a generic IT responsibility. Critical AI inputs should have named operational owners who understand the field in context, such as a clinical informatics lead for structured clinical documentation, a revenue-cycle owner for authorisation status, or a practice-operations owner for scheduling attributes.
For each critical element, document:
| Control | Practical question | |---|---| | Business definition | What does this field mean in the workflow? | | Source of record | Which system is authoritative? | | Steward | Who approves changes and resolves quality issues? | | Refresh expectation | How current must the value be for the use case? | | Completeness rule | When is a missing value acceptable or blocking? | | Escalation path | Who responds when quality drops? |
FHIR resources are helpful because they define modular components, data elements, constraints, and relationships that make up an exchangeable patient record. [1] However, teams still need local definitions and ownership. A standard resource name does not resolve differences in workflow use, coding practice, data-entry behaviour, or system configuration.
An API connection answers “can the data move?” AI governance also needs to answer “can we trace this output back to the information and transformation that produced it?”
Data lineage should identify the source system, extract time, transformation logic, vocabulary mappings, quality checks, and receiving system. Where a model uses derived features or summaries, the organisation should be able to identify the underlying fields and the rule that created the derivative.
This is essential when outputs are challenged. If a risk score changes unexpectedly, an investigation needs to distinguish among a clinical change, a new data feed, a missing value, an EHR configuration update, a mapping failure, or a model change. Without lineage, teams default to speculation and slow manual reconstruction.
For high-consequence use cases, preserve a versioned record of the data contract and mapping specification. Treat a material mapping change as a governed change that triggers validation—not as a routine integration ticket.
“Clean data” is not an adequate acceptance criterion. Data quality should be measured against the actual workflow. Four practical dimensions are particularly important:
Completeness. Are required fields present at the moment the AI process needs them? A clinical field completed hours after a workflow decision may be clinically accurate but operationally too late.
Conformance. Do values follow expected formats, code sets, and allowable ranges? Conformance catches structural errors but does not prove meaning.
Timeliness. Does the data reflect the current state of the patient, case, claim, schedule, or inventory? Timeliness thresholds should be tied to the decision cadence.
Plausibility. Do the values make sense in combination? For example, a completed authorisation status with no payer identifier or a closed encounter with future timestamps warrants review.
Set thresholds before deployment and monitor them after launch. A tool that operates correctly on complete test data may become unreliable when a source system changes, a field is no longer required, or a practice acquisition introduces a new data pattern.
AI workflows often fail at the seams between systems. A diagnosis, procedure, location, provider, or payer value may be represented differently across applications even when each system is functioning as designed. Vocabulary governance is the process of defining the canonical representation, mapping local variations, assigning an owner, and monitoring exceptions.
The CMS Interoperability and Prior Authorization Final Rule illustrates why this matters. The rule identifies FHIR R4.0.1, US Core, SMART App Launch, and FHIR Bulk Data Access among the required standards and specifications for affected payer APIs, and it encourages relevant implementation guides to reduce burden and increase interoperability. [2] Standards create a shared technical baseline; implementation still requires disciplined mapping and local testing.
Maintain a controlled change log for data contracts, mappings, code lists, and system interfaces. Every material change should identify the affected AI use cases, validation owner, testing evidence, effective date, and rollback option.
AI use may expand the number of systems, users, vendors, and derived outputs touching health information. Your data-governance programme should specify which data can be used for which purpose, whether data may be retained, how vendor access is controlled, whether data may be used to train a model, and how the organisation verifies those commitments.
The control model should include least-privilege access, approved data flows, auditability, contractual requirements for third parties, and a process for retiring access when a use case ends. The more rapidly a team can experiment with AI, the more important it becomes to distinguish a limited proof of concept from a production workflow with ongoing data rights and accountability.
Healthcare leaders do not need to solve every interoperability problem before starting. A focused 90-day sequence can create momentum:
Eunoia Consulting Co. helps healthcare organisations turn fragmented operational and clinical data into governed, AI-ready assets. Explore our Data Governance for Healthcare services to establish the controls that make interoperability useful in practice.
This article was produced by the Eunoia Consulting Co. Editorial Team. Eunoia Consulting Co. specialises in AI governance, healthcare operations, and data strategy for healthcare and veterinary organisations.
[1] ONC, HL7 FHIR
[2] CMS, Interoperability and Prior Authorization Final Rule